TTY Biopharm Company Limited (TPEX:4105)
Taiwan · Delayed Price · Currency is TWD 76.90
+0.40 (0.52%)
Sep 8, 2026, 1:30 PM CST
TTY Biopharm Company Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,654 | 6,453 | 5,894 | 5,506 | 5,062 | 4,536 |
Revenue Growth | 7.04% | 9.49% | 7.05% | 8.77% | 11.60% | 7.43% |
Gross Profit Gross Profit Growth | 3,831 | 3,721 | 3,415 | 3,287 | 3,021 | 2,768 |
Operating Income Operating Income Growth | 1,862 | 1,704 | 1,394 | 1,372 | 1,228 | 1,141 |
Net Income Net Income Growth | 1,733 | 1,559 | 1,450 | 1,129 | 1,094 | 831.89 |
Earnings Per Share EPS Growth | 6.96 | 6.26 | 5.82 | 4.53 | 4.40 | 3.34 |
EPS Growth | 9.60% | 7.56% | 28.48% | 2.96% | 31.74% | -9.97% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Healthcare Unit Healthcare Unit Growth | 265.67 | 263.43 | 262.41 | 195.63 | 581.66 | 221.48 |
Export and CDMO Business Unit Export and CDMO Business Unit Growth | 1,234 | 1,249 | 1,024 | 796.7 | 653.68 | - |
Adjustments and Eliminations Adjustments and Eliminations Growth | -480.49 | -512.98 | -444.41 | - | -268.62 | -274.72 |
Re-investment Business Unit Re-investment Business Unit Growth | 1,491 | 1,428 | 1,236 | 814.45 | 747.28 | - |
Oncology Business Unit Oncology Business Unit Growth | 2,618 | 2,505 | 2,464 | 2,430 | 2,341 | 2,769 |
Intensive Care Business Unit Intensive Care Business Unit Growth | 1,506 | 1,498 | 1,317 | 1,203 | 899.62 | 1,136 |
Other Business Unit Other Business Unit Growth | - | 21.92 | 35.23 | 65.44 | 106.64 | 270.72 |
Total Total Growth | 6,654 | 6,453 | 5,894 | 5,506 | 5,062 | 4,536 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,940 | 2,989 | 3,082 | 2,817 | 2,684 | 2,595 |
Total Debt Total Debt Growth | 2,064 | 1,216 | 1,711 | 1,859 | 1,805 | 2,145 |
Net Cash (Debt) Net Cash Growth | 876.14 | 1,773 | 1,371 | 957.65 | 878.78 | 450 |
Net Cash Growth | 126.82% | 29.36% | 43.11% | 8.97% | 95.28% | 6.52% |
Net Cash Per Share Net Cash Per Share Growth | 3.51 | 7.11 | 5.50 | 3.84 | 3.53 | 1.81 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,965 | 1,762 | 1,349 | 1,085 | 1,236 | 1,256 |
Capital Expenditures CapEx Growth | -127.67 | -94.61 | -125.16 | -78.35 | -91.52 | -60.32 |
Free Cash Flow Free Cash Flow Growth | 1,837 | 1,667 | 1,224 | 1,007 | 1,144 | 1,196 |
Free Cash Flow Growth | 26.45% | 36.19% | 21.57% | -12.00% | -4.33% | 233.86% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 57.57% | 57.66% | 57.94% | 59.70% | 59.69% | 61.03% |
Operating Margin | 27.98% | 26.41% | 23.65% | 24.93% | 24.26% | 25.15% |
Pretax Margin | 35.07% | 32.93% | 31.99% | 25.78% | 27.82% | 23.97% |
Profit Margin | 26.04% | 24.16% | 24.60% | 20.50% | 21.62% | 18.34% |
FCF Margin | 27.61% | 25.84% | 20.77% | 18.29% | 22.61% | 26.37% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 4.500 | 4.500 | 4.200 | 3.500 | 3.400 | 3.000 |
Dividend Per Share Growth | 7.14% | 7.14% | 20.00% | 2.94% | 13.33% | -25.00% |
Dividend Yield | 5.85% | 5.85% | 6.46% | 5.09% | 4.98% | 5.56% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.99 | 13.00 | 12.49 | 17.72 | 18.95 | 20.56 |
Forward PE | - | 13.74 | 16.18 | 14.81 | 17.45 | 16.54 |
P/FCF Ratio | 10.35 | 12.16 | 14.79 | 19.85 | 18.12 | 14.30 |
PS Ratio | 2.86 | 3.14 | 3.07 | 3.63 | 4.10 | 3.77 |